SCHEMBL2616645

SCHEMBL2616645

C/C(C=O)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(/C)C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
ALOX15 P16050 4/20 0.58
TSHR P16473 4/20 0.58
TDP1 Q9NUW8 3/20 0.58
RECQL P46063 2/20 0.58
HSD17B10 Q99714 2/20 0.58
PTGS1 P23219 2/20 0.56
MAPT P10636 4/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 3/20 0.43
NR1I2 O75469 1/20 0.43
PGR P06401 1/20 0.43
DRD3 P35462 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
CYP3A4 P08684 2/20 0.34
TRPV1 Q8NER1 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 1/20 0.34
APP P05067 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5074195 1.00 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL2832986 1.00 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL17366592 1.00 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903784 1.00 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
Methyl Alcohol SCHEMBL28459263 0.97 ALDH1A1 (0.56) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903775 0.93 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL4124093 0.93 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL21382193 0.93 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903782 0.93 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL4124094 0.93 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025110374-A1 RECOMBINANT YEAST FOR PRODUCING CROCIN AND PRECURSOR 아주대학교산학협력단 2025-05-30 WO claimed
CN-113234696-B Method for synthesizing crocetin in vitro 天津大学 2023-03-31 CN claimed
EP-3878954-A1 ENZYME GENE FOR BIOSYNTHESIS OF CROCIN AND USE THEREOF Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences (CN) 2021-09-15 EP claimed
CN-113234696-A Method for synthesizing crocetin in vitro 天津大学 2021-08-10 CN claimed
EP-3661951-A1 GENES AND METHODS FOR BIOTECHNOLOGICAL PRODUCTION AND COMPARTMENTALIZATION OF HIGH ADDED VALUE APOCAROTENOIDS Agenzia Nazionale Per Le Nuove Tecnologie, L'Energia E Lo Sviluppo Economico Sostenibile (ENEA) (IT) 2020-06-10 EP claimed
CN-110791510-A Screening identification and application of acetaldehyde dehydrogenase coding gene participating in crocetin synthesis 中国医学科学院药用植物研究所 2020-02-14 CN claimed
WO-2019025935-A1 GENES AND METHODS FOR BIOTECHNOLOGICAL PRODUCTION AND COMPARTMENTALIZATION OF HIGH ADDED VALUE APOCAROTENOIDS AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE (ENEA) (IT) 2019-02-07 WO claimed
EP-2742131-B1 METHODS AND MATERIALS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS EVOLVA SA (CH) 2018-11-28 EP claimed
US-9969989-B2 Carotenoid dioxygenase and methods for the biotechnological production in microorganisms and plants of compounds derived from saffron AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENER- GIA E LO SVILUPPO ECONOMICO SOSTENIBILE (ENEA) (IT) 2018-05-15 US claimed
US-20170306376-A1 Methods and Materials for Recombinant Production of Saffron Compounds EVOLVA SA (CH) 2017-10-26 US claimed
US-20170067063-A1 Methods for Recombinant Production of Saffron Compounds EVOLVA SA (CH) 2017-03-09 US claimed
EP-3114210-A2 METHODS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS Evolva SA (CH) 2017-01-11 EP claimed
US-9365561-B2 C5 benzothiazolyl sulfone compound, method of preparing preparing the same, method of preparing polyene dialdehyde compound using the same, and method of synthesizing lycopene using the same MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION (KR) 2016-06-14 US claimed
WO-2016012968-A1 A CAROTENOID DIOXYGENASE AND METHODS FOR THE BIOTECHNOLOGICAL PRODUCTION IN MICROORGANISMS AND PLANTS OF COMPOUNDS DERIVED FROM SAFFRON ENTE PER LE NUOVE TECNOLOGIE, L'ENERGIA E L'AMBIENTE (ENEA) (IT) 2016-01-28 WO claimed
US-20150376175-A1 C5 BENZOTHIAZOLYL SULFONE COMPOUND, METHOD OF PREPARING THE SAME, METHOD OF PREPARING POLYENE DIALDEHYDE COMPOUND USING THE SAME, AND METHOD OF SYNTHESIZING LYCOPENE USING THE SAME MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION (KR) 2015-12-31 US claimed
WO-2015132411-A2 METHODS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS EVOLVA SA (CH) 2015-09-11 WO claimed
US-20140248668-A1 Methods and Materials for Recombinant Production of Saffron Compounds EVOLVA SA (CH) 2014-09-04 US claimed
EP-2742131-A2 METHODS AND MATERIALS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS Evolva SA (CH) 2014-06-18 EP claimed
CN-103764818-A Methods and materials for recombinant production of saffron compounds EVOLVA SA 2014-04-30 CN claimed
WO-2013021261-A2 METHODS AND MATERIALS FOR RECOMBINANT PRODUCTION OF SAFFRON COMPOUNDS RAGHAVAN SHRIRAM (IN) 2013-02-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376175-A1 C5 BENZOTHIAZOLYL SULFONE COMPOUND, METHOD OF PREPARING THE SAME, METHOD OF PREPARING POLYENE DIALDEHYDE COMPOUND USING THE SAME, AND METHOD OF SYNTHESIZING LYCOPENE USING THE SAME ALOX12, ALOX5, NOTUM ALDH1A1 474/4885ALOX15 8/4885TSHR 4485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.